Cadila Healthcare has informed that it has enclosed a copy of press release dated May 24, 2021 titled ‘Zydus launches Ujvira (Trastuzumab Emtansine), a breakthrough in Breast Cancer treatment’.
The above information is a part of company’s filings submitted to BSE.